F-star Therapeutics, Inc.

CIK 1566373 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for F-star Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 20, 202315-12G0000947871-23-000338
Mar 17, 2023SC 13G0000935836-23-000333
Mar 13, 2023EFFECT9999999995-23-000558
Mar 13, 2023EFFECT9999999995-23-000561
Mar 13, 2023EFFECT9999999995-23-000564
Mar 13, 2023EFFECT9999999995-23-000560
Mar 13, 2023EFFECT9999999995-23-000563
Mar 9, 20238-K0001193125-23-065376
Mar 9, 202325-NSE0001354457-23-000164
Mar 9, 202340000899243-23-007665
Mar 9, 2023POS AM0001193125-23-065380
Mar 9, 2023POS AM0001193125-23-065385
Mar 9, 2023POS AM0001193125-23-065406
Mar 9, 2023POS AM0001193125-23-065395
Mar 9, 2023SC 14D9/A0001193125-23-065369
Mar 9, 2023S-8 POS0001193125-23-065425
Mar 9, 2023S-8 POS0001193125-23-065410
Mar 9, 202340000899243-23-007663
Mar 9, 202340000899243-23-007654
Mar 9, 202340000899243-23-007666
Mar 9, 202340000899243-23-007662
Mar 9, 202340000899243-23-007670
Mar 9, 2023S-8 POS0001193125-23-065416
Mar 9, 2023S-8 POS0001193125-23-065407
Mar 9, 2023S-8 POS0001193125-23-065412